skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved

Abstract

In HIV-1, the ability to mount antibody responses to conserved, neutralizing epitopes is critical for protection. Here we have studied the light chain usage of human and rhesus macaque antibodies targeted to a dominant region of the HIV-1 envelope second variable (V2) region involving lysine (K) 169, the site of immune pressure in the RV144 vaccine efficacy trial. We found that humans and rhesus macaques used orthologous lambda variable gene segments encoding a glutamic acid-aspartic acid (ED) motif for K169 recognition. Structure determination of an unmutated ancestor antibody demonstrated that the V2 binding site was preconfigured for ED motif-mediated recognition prior to maturation. Thus, light chain usage for recognition of the site of immune pressure in the RV144 trial is highly conserved across species. In conclusion, these data indicate that the HIV-1 K169-recognizing ED motif has persisted over the diversification between rhesus macaques and humans, suggesting an evolutionary advantage of this antibody recognition mode.

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; more »; ; ; ; ; ; ; ; ; ; ; ; « less
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES); Bill & Melinda Gates Foundation; National Institutes of Health (NIH)
OSTI Identifier:
1233905
Alternate Identifier(s):
OSTI ID: 1227575; OSTI ID: 1258693
Grant/Contract Number:  
W-31-109-Eng-38; P30-AI-64518; 5T32-AI007392; OPP1033098; UMI-AI100645
Resource Type:
Published Article
Journal Name:
Immunity
Additional Journal Information:
Journal Name: Immunity Journal Volume: 41 Journal Issue: 6; Journal ID: ISSN 1074-7613
Publisher:
Elsevier
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Wiehe, Kevin, Easterhoff, David, Luo, Kan, Nicely, Nathan I., Bradley, Todd, Jaeger, Frederick H., Dennison, S. Moses, Zhang, Ruijun, Lloyd, Krissey E., Stolarchuk, Christina, Parks, Robert, Sutherland, Laura L., Scearce, Richard M., Morris, Lynn, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, Sinangil, Faruk, Phogat, Sanjay, Michael, Nelson L., Kim, Jerome H., Kelsoe, Garnett, Montefiori, David C., Tomaras, Georgia D., Bonsignori, Mattia, Santra, Sampa, Kepler, Thomas B., Alam, S. Munir, Moody, M. Anthony, Liao, Hua-Xin, and Haynes, Barton F. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved. United States: N. p., 2014. Web. doi:10.1016/j.immuni.2014.11.014.
Wiehe, Kevin, Easterhoff, David, Luo, Kan, Nicely, Nathan I., Bradley, Todd, Jaeger, Frederick H., Dennison, S. Moses, Zhang, Ruijun, Lloyd, Krissey E., Stolarchuk, Christina, Parks, Robert, Sutherland, Laura L., Scearce, Richard M., Morris, Lynn, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, Sinangil, Faruk, Phogat, Sanjay, Michael, Nelson L., Kim, Jerome H., Kelsoe, Garnett, Montefiori, David C., Tomaras, Georgia D., Bonsignori, Mattia, Santra, Sampa, Kepler, Thomas B., Alam, S. Munir, Moody, M. Anthony, Liao, Hua-Xin, & Haynes, Barton F. Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved. United States. doi:10.1016/j.immuni.2014.11.014.
Wiehe, Kevin, Easterhoff, David, Luo, Kan, Nicely, Nathan I., Bradley, Todd, Jaeger, Frederick H., Dennison, S. Moses, Zhang, Ruijun, Lloyd, Krissey E., Stolarchuk, Christina, Parks, Robert, Sutherland, Laura L., Scearce, Richard M., Morris, Lynn, Kaewkungwal, Jaranit, Nitayaphan, Sorachai, Pitisuttithum, Punnee, Rerks-Ngarm, Supachai, Sinangil, Faruk, Phogat, Sanjay, Michael, Nelson L., Kim, Jerome H., Kelsoe, Garnett, Montefiori, David C., Tomaras, Georgia D., Bonsignori, Mattia, Santra, Sampa, Kepler, Thomas B., Alam, S. Munir, Moody, M. Anthony, Liao, Hua-Xin, and Haynes, Barton F. Mon . "Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved". United States. doi:10.1016/j.immuni.2014.11.014.
@article{osti_1233905,
title = {Antibody Light-Chain-Restricted Recognition of the Site of Immune Pressure in the RV144 HIV-1 Vaccine Trial Is Phylogenetically Conserved},
author = {Wiehe, Kevin and Easterhoff, David and Luo, Kan and Nicely, Nathan I. and Bradley, Todd and Jaeger, Frederick H. and Dennison, S. Moses and Zhang, Ruijun and Lloyd, Krissey E. and Stolarchuk, Christina and Parks, Robert and Sutherland, Laura L. and Scearce, Richard M. and Morris, Lynn and Kaewkungwal, Jaranit and Nitayaphan, Sorachai and Pitisuttithum, Punnee and Rerks-Ngarm, Supachai and Sinangil, Faruk and Phogat, Sanjay and Michael, Nelson L. and Kim, Jerome H. and Kelsoe, Garnett and Montefiori, David C. and Tomaras, Georgia D. and Bonsignori, Mattia and Santra, Sampa and Kepler, Thomas B. and Alam, S. Munir and Moody, M. Anthony and Liao, Hua-Xin and Haynes, Barton F.},
abstractNote = {In HIV-1, the ability to mount antibody responses to conserved, neutralizing epitopes is critical for protection. Here we have studied the light chain usage of human and rhesus macaque antibodies targeted to a dominant region of the HIV-1 envelope second variable (V2) region involving lysine (K) 169, the site of immune pressure in the RV144 vaccine efficacy trial. We found that humans and rhesus macaques used orthologous lambda variable gene segments encoding a glutamic acid-aspartic acid (ED) motif for K169 recognition. Structure determination of an unmutated ancestor antibody demonstrated that the V2 binding site was preconfigured for ED motif-mediated recognition prior to maturation. Thus, light chain usage for recognition of the site of immune pressure in the RV144 trial is highly conserved across species. In conclusion, these data indicate that the HIV-1 K169-recognizing ED motif has persisted over the diversification between rhesus macaques and humans, suggesting an evolutionary advantage of this antibody recognition mode.},
doi = {10.1016/j.immuni.2014.11.014},
journal = {Immunity},
number = 6,
volume = 41,
place = {United States},
year = {2014},
month = {12}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1016/j.immuni.2014.11.014

Citation Metrics:
Cited by: 24 works
Citation information provided by
Web of Science

Save / Share:

Works referencing / citing this record:

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
journal, July 2019


Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge
journal, June 2017

  • Bradley, Todd; Pollara, Justin; Santra, Sampa
  • Nature Communications, Vol. 8, Issue 1
  • DOI: 10.1038/ncomms15711

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
journal, July 2019


Assessing human B cell repertoire diversity and convergence
journal, June 2018

  • Imkeller, Katharina; Wardemann, Hedda
  • Immunological Reviews, Vol. 284, Issue 1
  • DOI: 10.1111/imr.12670

Common helical V1V2 conformations of HIV-1 Envelope expose the α4β7 binding site on intact virions
journal, October 2018

  • Wibmer, Constantinos Kurt; Richardson, Simone I.; Yolitz, Jason
  • Nature Communications, Vol. 9, Issue 1
  • DOI: 10.1038/s41467-018-06794-x

Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
journal, March 2017


Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques
journal, December 2016